2022Sep__-MB-COVID-19-Vaccine_-for-Individuals-Who-are-Planning-to-get-Pregnant-Currently-Pregnant-or-BreastfeedingDownload
2022May20-MB-COVID-19-Vaccine_-Updated-Interval-for-Booster-Doses-and-Expanded-Eligibility-for-Second-Booster-DosesDownload
2022April19-MB-Addendum-NO.-2-of-2-to-the-Manitoba-COVID-19-Vaccine_-Clinical-Practice-GuidelinesDownload
2022Mar02-MB-COVID-19-Vaccine_-mRNA-vaccine-supply-update-and-updated-interchangeability-guidance-for-individuals-aged-≥-30-yearsDownload
2021Dec24-MB-COVID-19-Vaccine_-updated-third_booster-dose-interval-for-individuals-aged-≥-50-years-and-updated-vaccine-product-for-individuals-aged-≥-30-yearsDownload
2021Dec10-MB-COVID-19-Vaccine_-updated-third_booster-dose-guidance-and-preferential-use-of-Pfizer_ComirnatyTM-for-12-to-29-year-oldsDownload
2021Nov10-MB-COVID-19-Vaccine-Update_-Expanded-Third_Booster-Dose-6-Months-After-Dose-2-GuidanceDownload
2021Oct05-MB-COVID-19-Vaccine_-Expansion-of-Third-Doses-to-Health-Care-Personnel-and-to-People-who-received-a-Viral-Vector-Vaccine-SeriesDownload
2021March29-MB-_-IMPORTANT-NOTICE_-Effective-immediately-pause-use-of-AstraZeneca-_-COVISHIELD-in-People-aged-_-55-years-_Download
2021March15-MB-COVID-19-Vaccine_-New_Updated-Communications-Products-including-Clinical-Practice-Guidelines-and-Consent-FormDownload
2021Mar10-MB-COVID-19-Vaccine-A-tool-for-practitioners-to-determine-and-document-patient-eligibility-for-the-AstraZeneca_COVISHIELD-vaccineDownload